Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the role of nimotuzumab in the neo-adjuvant setting in
patients with locally advanced HNSCC. The hypothesis is that the response would be increased
with the combination of nimotuzumab and cisplatin and fluorouracil (PF) regimen.